Patricia Pavlinac, MS, PhD

Assistant Professor, Global Health

Adjunct Assistant Professor, Epidemiology

 

Dr. Patricia Pavlinac, MS, PhD, is an epidemiologist and Assistant Professor in the Department of Global Health at the University of Washington. Dr. Pavlinac also co-directs the Gut Health and Child Survival scientific priority area of the Global Center for Integrated Health of Women, Adolescents and Children (Global WACh). Her research aims to identify interventions to halt morbidity and mortality attributed to enteric infectious diseases in children. Dr. Pavlinac has extensive experience coordinating pediatric studies in Kenya including her current role as Project Director of two clinical trials testing whether empiric use of a broad-spectrum antibiotic improves post-acute survival and growth in Kenyan children. These trials build on evidence that Kenyan children suffer an elevated risk of mortality and chronic malnutrition after acute infectious illnesses that may be due to inadequately treated or new exposure to bacterial pathogens. Nested in these trials, her team is also evaluating the impact of azithromycin on antimicrobial resistance to provide policy-makers with a balanced perspective on the costs and benefits of empiric azithromycin use. 

Publications

  1. Libby, TE, Karani, A, Tickell, KD, Akech, D, Singa, B, Rwigi, D et al.. The effect of a 5-day course of azithromycin on Streptococcus pneumoniae carriage and antimicrobial resistance among Kenyan children discharged from hospital. J Infect Dis. 2026; :. doi: 10.1093/infdis/jiag028. PubMed PMID:41542944 .
  2. Schiaffino, F, Parker, CT, Romaina Cachique, L, Garcia Bardales, PF, Liu, J, Peñataro Yori, P et al.. Robust Performance of Culture, qPCR, and Genomic Approaches for Shigella Serotyping in a Pediatric Surveillance Cohort. medRxiv. 2026; :. doi: 10.64898/2026.01.05.26343460. PubMed PMID:41542695 PubMed Central PMC12803388.
  3. Zhang, CX, Nuzhat, S, Islam, MR, Bashar, SJ, Das, S, Amin, R et al.. Population Pharmacokinetic and Pharmacodynamic Prediction for Tebipenem Pivoxil Treatment of Pediatric Shigellosis. Clin Transl Sci. 2026;19 (1):e70453. doi: 10.1111/cts.70453. PubMed PMID:41454572 PubMed Central PMC12743173.
  4. Schultes, OL, Hotwani, A, Pavlinac, PB, Hossain, MJ, Nasrin, D, Omore, R et al.. Defining severe shigellosis in the Enterics for Global Health study: A comparison of leading diarrhea severity definitions among children with Shigella diarrhea. J Infect Dis. 2025; :. doi: 10.1093/infdis/jiaf630. PubMed PMID:41379743 .
  5. Garcia Quesada, M, Breskin, A, Platts-Mills, JA, Benkeser, D, Pavlinac, PB, Galagan, SR et al.. Comparing existing and novel methods for estimating etiology-specific diarrheal disease incidence in hybrid surveillance studies. medRxiv. 2025; :. doi: 10.1101/2025.11.11.25339698. PubMed PMID:41292665 PubMed Central PMC12642700.
Search PubMed

Comments are closed.